Further Reduction in the Nonvertebral Fracture Rate Is Observed Following 3 Years of Denosumab Treatment: Results With Up to 7 Years in the FREEDOM Extension Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ferrari, Serge
  • Adachi, Jonathan Derrick
  • Zapalowski, Carol
  • Miller, Paul D
  • Reginster, Jean-Yves
  • Torring, Ove
  • Daizadeh, Nadia
  • Wang, Andrea
  • O'Malley, Cynthia
  • Wagman, Rachel B
  • Lewiecki, E Michael

publication date

  • February 1, 2013